Jones Financial Companies’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Sell |
16,541
-2,353
| -12% | -$195K | ﹤0.01% | 883 |
|
|
2025
Q1 | $1.59M | Sell |
18,894
-1,773
| -9% | -$150K | ﹤0.01% | 715 |
|
|
2024
Q4 | $1.86M | Buy |
20,667
+12,892
| +166% | +$1.16M | ﹤0.01% | 580 |
|
|
2024
Q3 | $765K | Buy |
7,775
+6,734
| +647% | +$663K | ﹤0.01% | 681 |
|
|
2024
Q2 | $96.5K | Buy |
1,041
+925
| +797% | +$85.7K | ﹤0.01% | 1062 |
|
|
2024
Q1 | $11K | Buy |
+116
| New | +$11K | ﹤0.01% | 1047 |
|
|
2023
Q1 | – | Sell |
-9
| Closed | -$1K | – | 793 |
|
|
2022
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 720 |
|
|
2021
Q2 | – | Sell |
-34
| Closed | -$5K | – | 797 |
|
|
2021
Q1 | $5K | Buy |
+34
| New | +$5K | ﹤0.01% | 632 |
|
|
2013
Q4 | – | Sell |
-267
| Closed | -$11K | – | 548 |
|
|
2013
Q3 | $11K | Hold |
267
| – | – | ﹤0.01% | 509 |
|
|
2013
Q2 | $9K | Buy |
+267
| New | +$9K | ﹤0.01% | 611 |
|